Arabian Journal of Chemistry · 2022 · 15 citations · 47 references
Life SciencesBotanyPlant SciencesFood AnalysisFood ChemistryPlant BiochemistryBioactive Food ComponentsMedicinal Plant KnowledgeMedicinal PlantsSeed Nutritional CompositionAnti-inflammatory ActivityAnti-inflammatory Natural ProductsOil Content YieldPhenolic Content AnalysisPhytochemical CompositionSeed Antioxidant CompoundsSeed Phytochemical ContentTotal Phenolic Content
Calotropis procera (Aiton) is a wildly grown shrubbery that has been used by traditional healers in various remedies for centuries. Its different organs are reported to possess a variety of biological activities. However, a few reports chemically investigated the seed fixed oil, but they didn’t prospect its bioactivity. Accordingly, this study aimed to investigate the phytochemical composition, physicochemical properties, and biological activity of the seed oil. As well, exploration of the best extraction method that give the highest oil yield with the best composition. Physicochemical properties, total phenolic content and oxidative stability index of the oil were estimated. GC–MS analysis identified the oil content. Anti- inflammatory activity was examined using a carrageenan-induced rat paw edema assay. Immunomodulatory activity was determined by measuring the pro-inflammatory cytokines levels. Moreover, In-vitro anti-parasitic and antioxidant activities were studied. Soxhlet extraction method gives the highest yield of 40.5 ± 0.76% with no time interval. The oil shows a physicochemical property within the AOCS standards and low phenol content. GC-MS analysis reveals unsaturated fatty acids account for 75.25% of the oil, with an abundance of oleic acid (33.64%) and linoleic acid (31.95%). The oil exhibited potent anti-inflammatory and immunomodulatory activity. At various dose levels, paw edoema volume, pro-inflammatory cytokines, tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and myeloperoxidase (MPO) serum levels were reduced. The seed oil is a promising candidate for the treatment of inflammation and/or inflammatory associated diseases (as parasitic infections) besides its immunomodulatory activity.
47
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Marc Feldmann, Ravinder N. Maini, James N. Woody et al. · The Lancet · 2020 · 552 citations · Full text
Oliver Dewald, Guofeng Ren, Georg Daniel Duerr et al. · American Journal Of Pathology · 2004 · 383 citations · Full text
PATHWAY TO CARRAGEENANINDUCED INFLAMMATION OF THE HIND LIMB OF THE RAT
Ralph Vinegar, James Truax, J H Selph et al. · 1987 · 280 citations
New Insights into Blastocystis spp.: A Potential Link with Irritable Bowel Syndrome
Philippe Poirier, Ivan Wawrzyniak, Christian P. Vivarès et al. · PLoS Pathogens · 2012 · 233 citations · Full text